| Patents for C07K 17 - Carrier-bound or immobilised peptides; Preparation thereof (10,673) |
|---|
| 03/07/2007 | EP1758937A2 Stable protein storage and stable nucleic acid storage in recoverable form |
| 03/07/2007 | EP1758621A1 Bioactive biomaterials for controlled delivery of active principles |
| 03/07/2007 | EP1547451A4 Cell adhesion resisting surfaces |
| 03/06/2007 | US7186686 Formulated composition |
| 03/01/2007 | WO2007023915A1 Imprint polymer and use thereof |
| 03/01/2007 | WO2006072048B1 Compositions and methods for identifying modulators of hausp |
| 03/01/2007 | US20070048806 Microarrays on mirrored substrates for performing proteomic analyses |
| 02/28/2007 | EP1757943A1 Array for identification of protein-protein interactions and method for manufacturing the same |
| 02/28/2007 | EP1757942A1 Array for identification of protein-protein interactions and method for manufacturing the same |
| 02/28/2007 | EP1756318A2 Aptamer-toxin molecules and method for using same |
| 02/28/2007 | EP1664085A4 Detecting molecules |
| 02/28/2007 | EP1471355B1 Method of fixing biomolecule to carrier |
| 02/28/2007 | EP1358253B1 Modifying the surface of polymer substrates by graft polymerisation |
| 02/28/2007 | EP1276491B9 Tamandarin and didemnin analogs and methods of making and using them |
| 02/28/2007 | CN1922202A Lsa-5 liver stage and blood stage antigen of plasmodium falciparum, immunogenic composition comprising said antigen, and vaccines against malaria |
| 02/28/2007 | CN1302050C Interpenetrating network polymer type super porous aquogel, its prepn. method and application |
| 02/27/2007 | USRE39497 Storage of materials |
| 02/27/2007 | US7183392 Site-specific, covalent bioconjugation of proteins |
| 02/27/2007 | US7183387 Polypeptide variants with altered effector function |
| 02/27/2007 | US7183081 Nucleotide sequences coding cytokine polypeptide for use in identifying modulator for treatment or arthritis, allergies, infections, inflammation, skin and cell proliferative disorders; wound healing agents |
| 02/27/2007 | US7183062 Prostaglandin receptor protein and methods of use thereof |
| 02/27/2007 | CA2218620C Synthesis of proteins by native chemical ligation |
| 02/22/2007 | WO2007021253A1 Compounds and methods for inhibiting hepatitis c virus replication |
| 02/22/2007 | WO2007021016A1 Photoregulated peptide, and method for regulation of peptide-protein complex formation using the photoregulated peptide |
| 02/22/2007 | WO2006097694A3 Peptide synthesis supported by a soluble polymer |
| 02/22/2007 | WO2006084007A3 Novel gene underlying atherosclerosis locus i |
| 02/22/2007 | US20070042442 Protein microarrays on mirrored surfaces for performing proteomic analyses |
| 02/22/2007 | US20070042431 Methods for reducing complexity of a sample using small epitope antibodies |
| 02/22/2007 | US20070042339 Preservation of biomaterials with transported preservation agents |
| 02/21/2007 | EP1328546B1 Cyclic peptides, method for preparing same and use as angiogenesis inhibitor or activator |
| 02/21/2007 | EP1280545B1 Cross-linked collagen matrices and methods for their preparation |
| 02/21/2007 | EP1137812B1 Dna-protein fusions and uses thereof |
| 02/20/2007 | US7179795 Nucleic acids encoding chimeric proteins comprising BMP-2 and a proteinase inhibitor |
| 02/20/2007 | US7179786 Variants of the NK1 fragment of hepatocyte growth factor/scatter factor (HGF/SF) and their use |
| 02/15/2007 | WO2006104964A3 Inhibition of wet type age related macular degeneration (amd) by adiponectin or acrp 30 |
| 02/15/2007 | US20070036826 Influenza immunogen and vaccine |
| 02/14/2007 | CN1913920A Influenza immunogen and vaccine |
| 02/14/2007 | CN1911447A Transferrin-polyethylene glycol medicine molecular compound and its use |
| 02/14/2007 | CN1300139C Haptens, immunogens, antibodies and conjugates for 2-oxo-3-hydroxy LSD |
| 02/13/2007 | CA2219947C Monoclonal antibody reactive to human cetp and assay method for human cetp |
| 02/08/2007 | WO2007014447A1 Gelation of undenatured proteins with polysaccharides |
| 02/08/2007 | WO2006121852A3 Anti-cd19 antibody therapy for autoimmune disease |
| 02/08/2007 | WO2006091734A3 Compositions and methods for classifying biological samples |
| 02/08/2007 | US20070032636 Chimeric retroviral Gag genes and screening assays |
| 02/08/2007 | US20070032635 Prevention and treatment of HCV infection employing antibodies directed against conformational epitopes |
| 02/08/2007 | US20070032433 Novel peptides as NS3-serine protease inhibitors of hepatitis C virus |
| 02/08/2007 | US20070032421 Methods and compositions relating to cystatin C |
| 02/08/2007 | US20070032405 Branched water-soluble polymers and their conjugates |
| 02/08/2007 | US20070031484 Immunoliposomes that optimize internationalization into target cells |
| 02/08/2007 | CA2617802A1 Gelation of undenatured proteins with polysaccharides |
| 02/07/2007 | EP0833906B1 Novel ctla4/cd28 ligands and uses therefor |
| 02/07/2007 | CN1909979A Method for coating an object with hydrophobin at low temperature |
| 02/07/2007 | CN1908014A Modified peptides as therapeutic agents |
| 02/06/2007 | US7172907 2-{5-[1-(5-carboxypentyl)-3,3-dimethyl-1,3-dihydro-2H-indol-2-ylidene]-3-cyano-1,3-pentadienyl}-1,3,3-trimethyl-3H-indolinium (mesocyano Cy5); for sequencing, microarrays, flow cytometry and proteomics |
| 02/06/2007 | US7172905 Polypeptide immobilization |
| 02/06/2007 | US7172682 Enzyme immobilization for electroosmotic flow |
| 02/06/2007 | CA2132507C Method for altering hair growth and compositions used therefore |
| 02/01/2007 | WO2007012605A2 Static support bed for purification, separation, detection, modification and/or immobilization of target entities and method using thereof |
| 02/01/2007 | WO2007012144A1 Compositions and methods for growth of pluripotent cells |
| 02/01/2007 | WO2006116260A3 Modulation of antibody effector function by hinge domain engineering |
| 02/01/2007 | WO2005062959A3 Isolated t lymphocyte receptors specific for human autoantigens complexed with human mhc molecules and methods of making and using same |
| 02/01/2007 | US20070026487 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/01/2007 | US20070025965 Therapies for renal failure using interferon-beta |
| 02/01/2007 | CA2616863A1 Compositions and methods for growth of pluripotent cells |
| 02/01/2007 | CA2616521A1 Method of treating or preventing tissue deterioration, injury or damage due to congestive heart failure |
| 02/01/2007 | CA2616087A1 Static support bed for purification, separation, detection, modification and/or immobilization of target entities and method using thereof |
| 01/31/2007 | EP1748078A2 Methods, kits and compositions of combination oligomers |
| 01/31/2007 | EP1746902A2 Multi-lectin affinity chromatography and uses thereof |
| 01/31/2007 | CN1905900A Targeting of ERB antigens |
| 01/31/2007 | CN1905806A Gel-shell beads with adsorbed or bound biomolecules |
| 01/30/2007 | US7169989 Applying an enzyme for the selective removal of sub-unit parts of the polymer to at least one predetermined area of said polymeric substrate via a pipette with a nano-sized orifice |
| 01/30/2007 | US7169907 Derivatives, immunogens, and antibodies for detecting ecstasy-class drugs |
| 01/30/2007 | US7169898 Soluble CD83 proteins and use thereof for the treatment or prevention of a disease or medical condition caused by dysfunction or undesired function of a cellular immune response involving T cells |
| 01/30/2007 | US7169894 Methods and compositions for reverse translation |
| 01/30/2007 | US7169892 Wherein the lipid is conjugated to the amino terminus of the peptide by a peptide bond and the water-soluble polymer is conjugated to the carboxy terminus of the peptide by a peptide bond; for use as colloidal carriers and the like of tissue-specific drug delivery systems |
| 01/30/2007 | US7169754 Blood disorders; drug in aqueous solution |
| 01/25/2007 | WO2007010623A1 Novel polypeptide and method for producing the same |
| 01/25/2007 | WO2006031607A3 A method of treating cancer |
| 01/25/2007 | US20070021588 Alpha macroglobulin protein family members |
| 01/25/2007 | US20070020681 Analyte reacts to form a binding pair, localized on a solid phase support, using an analyte-dependent enzyme activation system; an enzyme reacts with the labeled conjugate forming an activated conjugate, binds to a receptor site for the conjugate; labeled, glycoside ester substituted benzene substrate |
| 01/24/2007 | EP1745289A2 Methods and antibodies for nitrofuran detection |
| 01/24/2007 | EP1402055B1 Method for producing a layer of functional molecules |
| 01/24/2007 | EP1137690B2 Peg-based macromonomers, chemically inert polymers prepared therefrom and the use of these polymers for organic synthesis and enzyme reactions |
| 01/24/2007 | CN1902496A Binding assay components |
| 01/23/2007 | US7166708 Reacting a protein with a hapten (especially a luteinizing hormone releasing hormone peptides derived from E coil, or malaria derived peptides) to produce a hapten-protein conjugate, followed by reacting the hapten-protein conjugate with a polysaccharide |
| 01/23/2007 | US7166702 Used to treat inflammatory responses associated with activation, proliferation and migration of immune effector cells, including leukocyte cell types, neutrophils, macrophages, and eosinophils |
| 01/23/2007 | US7166440 2,4,5-trichlorophenoxyalkyl carboxylic acid and a method for determining dioxins using the same |
| 01/23/2007 | US7166436 Compound for use as diagnostic tool in protein analysis |
| 01/23/2007 | US7166304 Degradable heterobifunctional poly(ethylene glycol) acrylates |
| 01/18/2007 | WO2006125140A3 Methods for treating fibrotic conditions |
| 01/18/2007 | WO2006113958A8 Affinity ligands |
| 01/18/2007 | WO2006105448A3 Proliferation of muc1 expressing cells |
| 01/18/2007 | WO2006072048A3 Compositions and methods for identifying modulators of hausp |
| 01/18/2007 | WO2004054510A3 Method for identifying modulators of human orexin-2 receptor |
| 01/17/2007 | CN1896103A N-terminally monopegylated polypeptides and process for their preparation |
| 01/16/2007 | US7164002 FVIIa antagonists |
| 01/16/2007 | US7163683 Inducing specific B cell anergy to an immunogen comprising a conjugate of a nonimmunogenic valency platform molecule and an analog of the immunogen that (a) binds specifically to B cells to which the immunogen binds and (b) lacks the T cell epitope(s) of the immunogen |
| 01/11/2007 | WO2007003781A1 Fluorescent polymers soluble in an aqueous solution and a method for the production thereof |
| 01/11/2007 | US20070009605 Encapsulation of water soluble peptides |
| 01/11/2007 | US20070009569 Delivery device for topical, oral, intravenous, intraperitoneal, intramuscular, transdermal, nasal, or iontophoretic administration coated with a RNAIII inhibiting heptapeptide of the sequence Tyr-X2-Pro-X1-Thr-Asn-Phe where X1 is Cys, Trp or Ile, and X2 is Lys or Ser; antibiotic resistance |